PBProdip Kumar Baral

Prodip Kumar Baral

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prodip Kumar Baral has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Allium cepa bulbs and Allium sativum cloves host different strains of Fusarium oxysporum with distinct bioactivities

    by Mobarak Hossain, Mohaimenul Hoque, Abdullah Bin Khaled, Puja Roy, Prodip Kumar Baral

    Plant-fungi interaction serves various insights for research. Therefore, the study aimed to isolate endophytic fungi from Allium cepa (onion) bulbs and Allium sativum (garlic) cloves to evaluate the biological activity of their metabolites. Remarkably, a heteromorphic strain of Fusarium oxysporum was successfully isolated and identified via Internal Transcribed Spacer (ITS) amplicon sequencing: the strain from onion was designated ACE (OR062575), and the one from garlic as ASE (OR062574). Morphologically, ACE spores exhibited no defined shape, whereas ASE produced oval and amygdaloid chlamydospores. The fungal extracts were evaluated using the free radical scavenging DPPH assay, antimicrobial disc diffusion method, and brine shrimp lethality bioassay. Notably, ASE demonstrated approximately 1.5 times higher 50% free radical inhibition compared to ACE. The ACE extract (80 µg/disc) showed significant antibacterial activity against Escherichia coli (18 mm) and Bacillus megaterium (16 mm), whereas ASE exhibited roughly half this activity at the same dose against E. coli and Pseudomonas aeruginosa. Interestingly, the cytotoxicity of ACE had a logarithmic 50% lethal dose of 0.44 µm/ml, and no significant difference was observed from the reference vincristine sulfate. These findings highlight the need for further investigation into how different Allium species influence fungal genetic variation and metabolic activities.

  • Open Access

    Inhaled Antibiotic and Biologic Formulations Targeting Pseudomonas aeruginosa

    by Prodip Kumar Baral, Jack Dummer, Daniel Pletzer, Shyamal C. Das

    Lower respiratory tract infections caused by Pseudomonas aeruginosa are a global concern. Patients with chronic lung diseases such as cystic fibrosis and non-cystic fibrosis bronchiectasis often do not receive adequate antibiotic delivery through conventional routes. P. aeruginosa employs several mechanisms, including biofilm formation and efflux pumps to limit the accumulation of bactericidal drug concentrations. Direct drug delivery to the lung epithelial lining fluid can increase antibiotic concentration and reduce treatment failure rates. This review discusses current research and developments in inhaled antibiotic formulations for treating P. aeruginosa infections. Recent studies on particle engineering for the dry powder inhalers of antibiotics emphasized three fundamental principles of development: micro, nano, and nano-in-microparticles. Carrier-free microparticles showed potential for high-dose delivery but suffered from poor aerosolization, which could be improved through a drug–drug combination. Amino acids in a co-spray-dried system improved powders’ aerodynamics and reduced moisture sensitivity while incorporating the chitosan/poly(lactic-co-glycolic acid) (PLGA)-modified release of the drug. Nano-in-microsystems, embedding lipid carriers, showed improved antibiofilm activity and controlled release. We also highlight emerging biologics, including antibacterial proteins/peptides, vaccines, bacteriophages, and probiotics. Research on antibiotics and biologics for inhalation suggests excellent safety profiles and encouraging efficacy for some formulations, including antimicrobial peptides and bacteriophage formulations. Further research on novel molecules and synergistic biologic combinations, supported by comprehensive animal lung safety investigations, will be required in future developments.


  • Open Access

    Public Awareness and Personal Hygienic Practices of Rural People in the COVID-19 Situation

    by Prodip Kumar Baral, Umme Habiba, Emdadul Islam, S. M. Woahid Murad

    Background: The study attempted to understand rural Bangladesh's health information, awareness level, and preventive measures in the Coronavirus disease -19 (COVID-19) pandemic. Methods: A cross-sectional survey by face-to-face interview was conducted with rural people from 14 June 2020 to 13 August 2020. An ordered logistic regression model was employed for data analysis. A total of 3,007 people (Female = 55.97%; Male = 44.03%) participated in the survey who met the inclusion criteria. Results: The demography of respondents revealed that a significant portion of villagers were within the ages 21-30 (26.80%), had primary education (23.88%), unemployed (31.73%), and middle class (56.17%). The most common and influential used media to know about the Coronavirus disease were electronic media and relative/family/friend/neighbors. Change of demography created a spectacular difference in public awareness level and hygiene practice. Female, illiterate, poor, and age above 60 were comparatively less aware of seven essential facts about the disease. There was no mentionable difference in personal hygienic practices due to sex. But particpants who were aged 51-60 years, graduates or postgraduates, unmarried, government or non-government employees and middle class exhibitedthe best hygiene practice over other features. Invariably, the education level of rural people had a positive effect on awareness and preventive measures. Conclusions: Overall, the government and policymakers must identify vulnerable groups whose awareness and hygienic practices are not at the optimum level. Afterward, the government and related organizations should take necessary measures immediately to protect these groups from COVID-19 threats until the complete immunization.


  • Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

    by Prodip Kumar Baral, Mohammad Tohidul Amin, Mamun Or Rashid, Mohammad Salim Hossain

    Pooled evidence conveys the association between polyunsaturated fatty acids and infectious disease. SARS-CoV-2, an enveloped mRNA virus, was also reported to interact with polyunsaturated fatty acids. The present review explores the possible mode of action, immunology, and consequences of these polyunsaturated fatty acids during the viral infection. Polyunsaturated fatty acids control protein complex formation in lipid rafts associated with the function of two SARS-CoV-2 entry gateways: angiotensin-converting enzyme-2 and cellular protease transmembrane protease serine-2. Therefore, the viral entry can be mitigated by modulating polyunsaturated fatty acids contents in the body. α-Linolenic acid is the precursor of two clinically important eicosanoids eicosapentaenoic acid and docosahexaenoic acid, the members of ω-3 fats. Resolvins, protectins, and maresins derived from docosahexaenoic acid suppress inflammation and augment phagocytosis that lessens microbial loads. Prostaglandins of 3 series, leukotrienes of 5 series, and thromboxane A3 from eicosapentaenoic acid exhibit anti-inflammatory, vasodilatory, and platelet anti-aggregatory effects that may also contribute to the control of pre-existing pulmonary and cardiac diseases. In contrast, ω-6 linoleic acid-derived arachidonic acid increases the prostaglandin G2, lipoxins A4 and B4, and thromboxane A2. These cytokines are pro-inflammatory and enhance the immune response but aggravate the COVID-19 severity. Therefore, the rational intake of ω-3-enriched foods or supplements might lessen the complications in COVID-19 and might be a preventive measure. Graphic Abstract